BGI Diagnostics

BGI was founded in 1999 with the vision of using genomics to benefit humanity and has since become the world's largest genomics organization. BGI includes a private non-profit research institute and a commercial sequencing applications division. Together with its affiliated branches, BGI Americas and BGI Europe, BGI has established partnerships with leading academic and government research institutions as well as global biotechnology and pharmaceutical companies to support a wide range of healthcare, agriculture, environmental, and related applications. By combining high-throughput, cost-effective genomics platforms, robust sample collection and storage capabilities, in-depth bioinformatics analysis, and a core commitment to education, BGI is dedicated to ensuring that omics science and technology can be used for the benefit of all.The NIFTY® test is our market-leading non-invasive prenatal test (NIPT), offered by over 2,000 partners in more than 50 countries worldwide. As of January 2019, we have processed over 4,000,000 test samples, making NIFTY® the most trusted NIPT globally.